20 March 2018
Dr. Salha Bujassoum, Senior Consultant, Hematology and Oncology, and Director of the Hereditary and High-Risk Screening Program at Hamad Medical Corporation (HMC), has announced that in 2017, 800...
Subscribe to Salha Bujassoum